Pulmonary Embolism Imaging and Clinical Pearls for Boards

On boards, pulmonary embolism is a pattern-recognition question wearing a clinical disguise. The imaging gold standard is CT pulmonary angiography (CTA), where you look for an intraluminal filling defect in a pulmonary artery. The classic EKG buzzword is S1Q3T3, but sinus tachycardia is the finding you'll actually see most. Before you image, the stem is usually testing whether you know the Wells score and the PERC rule well enough to decide between a D-dimer, a CTA, and doing nothing at all.

That last point is where most students lose the question. The vignette rarely shows you a saddle embolus on a platter. It hands you a leg swelling, a tachycardic patient, a recent surgery, and asks for the next step. The board task is to move through pretest probability, the right test for that probability, and then management, in that order. Get the order right and PE stops being a guessing game.

Why does pulmonary embolism get tested so heavily on boards?

PE is high-yield because one vignette can test physiology, risk factors, EKG reading, imaging, and management all at once. That density is exactly what NBOME and USMLE writers want from a single question. A well-built PE stem forces you to integrate Virchow's triad, a pretest probability tool, an imaging choice, and a treatment decision, which is why it shows up on COMLEX Level 1, USMLE Step 1, and again in a more clinical wrapper on COMLEX Level 2-CE and USMLE Step 2 CK.

The other reason is that PE has famous distractors. S1Q3T3 sounds like the answer to every PE EKG question, so writers reward the student who knows it's uncommon. D-dimer sounds like a great test, so writers punish the student who orders it in a high-probability patient. The trap is baked into the buzzwords, and knowing the buzzword without knowing its limits is how you get burned.

Risk factors trace back to Virchow's triad, and boards expect you to map a stem onto it:

• Stasis: long-haul flights, prolonged immobilization, recent hospitalization, casting of a limb
• Endothelial injury: recent surgery (especially orthopedic), trauma, central lines
• Hypercoagulability: malignancy, pregnancy and postpartum, estrogen (OCPs, hormone replacement), Factor V Leiden, antiphospholipid syndrome, nephrotic syndrome

When the stem stacks two of these on a dyspneic, tachycardic patient, PE should already be at the top of your differential before you reach the imaging line.

What does a PE look like on CTA?

On CT pulmonary angiography, an acute pulmonary embolism appears as a filling defect: a dark, low-attenuation clot sitting inside a contrast-opacified pulmonary artery. CTA is the imaging gold standard for suspected PE in a hemodynamically stable patient with adequate renal function and no contrast allergy. It's fast, widely available, and it can also reveal alternative diagnoses like pneumonia, aortic dissection, or a pleural effusion when the story turns out not to be PE.

The classic descriptions boards use for a CTA-detected clot:

• Intraluminal filling defect: the clot outlined by contrast on either side, the single most testable finding
• Saddle embolus: a large clot straddling the bifurcation of the main pulmonary artery, the buzzword for a big, hemodynamically threatening PE
• Right heart strain signs on the same CT: right ventricular dilation with an RV-to-LV ratio greater than 1, and bowing of the interventricular septum toward the left

A saddle embolus is worth memorizing because the image is memorable and because it signals the patient may be tipping toward a massive PE. Size on imaging does not define "massive," though. That label is hemodynamic, and we'll come back to it in management.

The EKG findings: S1Q3T3 and what actually shows up

S1Q3T3 is the EKG buzzword every board question dangles: a prominent S wave in lead I, a Q wave in lead III, and an inverted T wave in lead III. It reflects acute right heart strain from the sudden rise in pulmonary vascular resistance. Here's the pearl that separates the students who pass from the students who overtrust the buzzword: S1Q3T3 is neither sensitive nor specific, and it shows up in a minority of PE patients.

The finding you'll actually see most often is sinus tachycardia. If a board EKG in a dyspneic postoperative patient shows nothing but a fast, regular rhythm, that is entirely consistent with PE and should not talk you out of the diagnosis. Beyond tachycardia and S1Q3T3, other strain patterns can appear:

• New or incomplete right bundle branch block
• T-wave inversions in the right precordial leads (V1 through V4), a sign of RV strain
• Right axis deviation
• P pulmonale (peaked P waves) in some cases

The board move is to treat any of these as supportive but never confirmatory. An EKG cannot rule PE in or out. It raises or lowers your suspicion and points you toward the right imaging decision.

What chest X-ray signs suggest pulmonary embolism?

The most important chest X-ray pearl for PE is that the film is usually normal or near-normal, and a normal CXR in a dyspneic, hypoxic patient with clear lungs should raise your suspicion rather than lower it. When the CXR does show something, boards test three named signs, all of them classic and all of them uncommon in practice.

• Hampton's hump: a wedge-shaped, pleura-based opacity representing pulmonary infarction, with the base against the pleural surface
• Westermark sign: a focal area of decreased vascular markings (oligemia) distal to the occluded vessel
• Fleischner sign: an enlarged, prominent central pulmonary artery

The reason CXR still matters on boards is that it helps exclude mimics. A dyspneic, hypoxic patient with a lobar consolidation is pointing you toward pneumonia. A large pneumothorax or a huge effusion reframes the whole vignette. So the CXR is rarely the answer to "how do you diagnose PE," but it's frequently the tool that rules out the impostor sitting in the same differential.

A quick word on arterial blood gas, since boards pair it with PE: the classic ABG shows hypoxemia with hypocapnia and a respiratory alkalosis, driven by tachypnea, plus a widened alveolar-arterial (A-a) gradient. A normal A-a gradient makes PE less likely but does not exclude it, especially with a small clot.

How do you use the Wells score and PERC rule?

The Wells score estimates pretest probability of PE, and it drives your next step: a low-probability patient can be worked up with a D-dimer, while a high-probability patient goes straight to CTA. The PERC rule is a separate tool used only in patients already judged low-risk, and if all eight PERC criteria are negative, you can rule out PE without even ordering a D-dimer. Boards love these because they test whether you image reflexively or reason first.

The Wells criteria for PE assign points as follows:

In the common two-tier interpretation, a score greater than 4 means PE is likely (go to CTA), and a score of 4 or less means PE is unlikely (get a D-dimer). If the D-dimer is negative in that unlikely group, you've effectively excluded PE. If it's positive, you move to CTA.

The PERC rule is the tool that keeps you from ordering a D-dimer in the first place. It applies only to patients you've already classified as low-risk, and all eight must be negative to rule PE out clinically:

1. Age under 50
2. Heart rate under 100/min
3. Oxygen saturation of 95 percent or higher on room air
4. No hemoptysis
5. No estrogen use
6. No prior DVT or PE
7. No unilateral leg swelling
8. No surgery or trauma requiring hospitalization within the past 4 weeks

If even one PERC criterion is positive in a low-risk patient, you cannot use PERC to exclude PE and you proceed to a D-dimer. The high-yield trap: applying PERC to a high-risk patient. PERC is a rule-out tool for low pretest probability only, and using it to dismiss a high-probability presentation is a classic wrong answer.

When do you skip the D-dimer and image directly?

Skip the D-dimer and go straight to CTA when pretest probability is high, because a negative D-dimer in a high-probability patient does not lower the post-test probability enough to rule PE out. D-dimer is a sensitive but nonspecific test, so its value is in ruling PE out in low-to-intermediate probability patients, not in confirming it or in clearing a high-risk one.

D-dimer rises in plenty of conditions that have nothing to do with clot: infection, malignancy, pregnancy, recent surgery, trauma, and advancing age. That's why a positive D-dimer never confirms PE. It only tells you the negative result would have been useful, and since it wasn't negative, you now need imaging. Some boards test the age-adjusted D-dimer cutoff (age times 10 ng/mL in patients over 50) to reduce false positives, so recognize it if it appears.

When CTA is the right test but the patient can't get iodinated contrast, the alternative is a ventilation-perfusion (V/Q) scan. Reach for V/Q when there is renal impairment, a contrast allergy, or a desire to limit radiation in a younger patient. A V/Q scan reads as a mismatch: a perfusion defect in a segment that ventilates normally. It works best when the baseline chest X-ray is clear, and it becomes hard to interpret in patients with a lot of underlying lung disease.

Pregnancy deserves its own note, since it's a favorite board scenario. A dyspneic pregnant patient with suspected PE is often worked up starting with a lower-extremity compression ultrasound (looking for DVT, which would justify anticoagulation without further imaging), then CTA or V/Q depending on the chest X-ray and institutional protocol. The point boards test is that pregnancy is a hypercoagulable state, PE is a leading cause of maternal mortality, and you do not withhold a needed diagnostic study out of radiation fear.

How is pulmonary embolism managed on board questions?

The default management of acute PE is anticoagulation, and the escalation question is whether the patient is hemodynamically unstable enough to need thrombolysis. A stable patient with a confirmed PE gets anticoagulated. A patient with sustained hypotension from the PE (a massive PE) is the one boards want you to escalate to thrombolytics, assuming no contraindication to bleeding.

The classifications you need for the "next step" question:

Anticoagulation specifics that show up on Step 2 CK and Level 2-CE:

• Initial anticoagulation: low-molecular-weight heparin, unfractionated heparin, or fondaparinux. Unfractionated heparin is favored when the patient is unstable or thrombolysis is on the table, because it's easily reversible and short-acting.
• Long-term anticoagulation: a DOAC (apixaban, rivaroxaban) is first-line for most patients. Warfarin bridged with heparin is used in specific situations. LMWH is preferred in active malignancy and in pregnancy (warfarin and DOACs are avoided in pregnancy).
• IVC filter: reserved for patients with a contraindication to anticoagulation (active bleeding) or recurrent PE despite adequate anticoagulation. It is not a substitute for anticoagulation when anticoagulation is safe.

The single most common management trap is reaching for thrombolytics in a stable submassive PE just because the CT looked scary or the troponin was up. Massive is defined by hemodynamics, not by clot size or a mildly elevated biomarker. If the blood pressure is holding, the default is anticoagulation.

Common board pitfalls and how to avoid them

Pitfall 1: Trusting a normal EKG or normal CXR to exclude PE. Sinus tachycardia or a completely normal tracing is compatible with PE, and the CXR is often clean. Neither test rules it out. If the story fits, keep moving toward pretest probability and imaging.

Pitfall 2: Ordering a D-dimer in a high-probability patient. A negative D-dimer does not clear a high pretest probability, and a positive one just delays the CTA you already needed. In the high-probability patient, image directly.

Pitfall 3: Applying PERC to a high-risk patient. PERC is a rule-out tool for patients already judged low-risk. Using it to dismiss a high-probability presentation is a designed-in wrong answer.

Pitfall 4: Calling a PE "massive" based on the CT. A saddle embolus on imaging is not automatically a massive PE. The massive label requires sustained hypotension or shock. Read the vitals before you escalate to thrombolytics.

Pitfall 5: Using warfarin or a DOAC in pregnancy. Warfarin is teratogenic and DOACs are avoided in pregnancy. The pregnant patient with PE gets LMWH. This is a frequent Step 2 CK and Level 2-CE distractor.

Pitfall 6: Forgetting the IVC filter indication. An IVC filter is for the patient who cannot be anticoagulated or who fails anticoagulation, not for routine PE. Reaching for a filter in an anticoagulatable patient is wrong.

Practice questions

These two questions test the reasoning chain directly. Cover the answer choices, work the stem, then check yourself against the explanation.

Question 1

A 61-year-old woman presents to the emergency department with acute dyspnea and pleuritic chest pain that began 2 hours ago. She underwent a total knee arthroplasty 10 days earlier and has been largely immobile since. Vital signs include temperature 37.1°C (98.8°F), heart rate 118/min, respiratory rate 24/min, blood pressure 128/78 mm Hg, and oxygen saturation 91 percent on room air. The right calf is swollen and tender. Lungs are clear to auscultation. An electrocardiogram shows sinus tachycardia. A chest radiograph is unremarkable. Which of the following is the most appropriate next step in management?

A. Obtain a D-dimer level B. Obtain CT pulmonary angiography C. Begin empiric intravenous antibiotics D. Administer intravenous alteplase E. Obtain a ventilation-perfusion scan

Correct answer: B

This patient has a high pretest probability of pulmonary embolism. Recent orthopedic surgery, immobilization, clinical signs of a DVT (unilateral swollen tender calf), tachycardia, and hypoxia stack multiple Wells criteria and push the score into the "PE likely" range. In a high-probability patient, the next step is CT pulmonary angiography, not a D-dimer, because a negative D-dimer would not lower the post-test probability enough to exclude PE (A is wrong). Empiric antibiotics treat a pneumonia the clear lungs and clean chest film argue against (C is wrong). Alteplase (thrombolysis) is reserved for massive PE with sustained hypotension; this patient is normotensive, so anticoagulation, not thrombolytics, would follow a confirmed diagnosis (D is wrong). A V/Q scan is the alternative when CTA is contraindicated by renal impairment or contrast allergy, neither of which is present here, so CTA remains the first-line study (E is wrong).

Question 2

A 44-year-old man is admitted with a large pulmonary embolism confirmed on CT pulmonary angiography, including a clot straddling the main pulmonary artery bifurcation. Shortly after admission his blood pressure falls to 78/44 mm Hg and remains low despite a fluid bolus. Heart rate is 128/min and oxygen saturation is 88 percent on supplemental oxygen. He has no history of bleeding, recent surgery, or stroke. Which of the following is the most appropriate next step in management?

A. Start low-molecular-weight heparin alone B. Place an inferior vena cava filter C. Administer systemic thrombolytic therapy D. Obtain a lower-extremity compression ultrasound E. Start oral apixaban

Correct answer: C

This is a massive pulmonary embolism, defined by sustained hypotension and shock from the PE rather than by the size of the clot on imaging. In a hemodynamically unstable patient with no contraindication to bleeding, systemic thrombolysis (for example, tPA) is the appropriate escalation to rapidly lyse the clot and relieve right ventricular strain (C is correct). Anticoagulation alone, whether LMWH or a DOAC like apixaban, is the treatment for a stable PE and is insufficient for a patient in shock (A and E are wrong). An IVC filter is reserved for patients who cannot be anticoagulated or who have recurrent PE despite anticoagulation, and it does nothing for the existing hemodynamically significant clot (B is wrong). A compression ultrasound would add nothing here because the PE is already confirmed and the patient is unstable (D is wrong).

Frequently asked questions about pulmonary embolism on boards

Is S1Q3T3 the most common EKG finding in pulmonary embolism?

No. S1Q3T3 is the classic buzzword and it reflects acute right heart strain, but it appears in only a minority of PE patients. The most common EKG finding is sinus tachycardia. Boards test this gap deliberately: a stem may show only a fast, regular rhythm to see whether you'll dismiss PE because the tracing lacks the famous strain pattern. Other supportive findings include a new right bundle branch block, T-wave inversions in leads V1 through V4, and right axis deviation. Treat all of them as suggestive, never confirmatory.

When should I order a D-dimer versus going straight to CTA?

Order a D-dimer when pretest probability is low or intermediate, because a negative result can rule PE out in that group. Go straight to CT pulmonary angiography when pretest probability is high, since a negative D-dimer won't lower the risk enough to exclude PE and a positive one just delays imaging you already needed. D-dimer is sensitive but nonspecific, so it rises in infection, malignancy, pregnancy, recent surgery, and old age. A positive D-dimer never confirms PE; it only tells you imaging is now required.

What is the difference between the Wells score and the PERC rule?

The Wells score estimates pretest probability and sorts patients into "PE likely" (proceed to CTA) or "PE unlikely" (get a D-dimer). The PERC rule is a separate rule-out tool used only in patients already judged low-risk. If all eight PERC criteria are negative, PE can be excluded clinically without even a D-dimer. The critical board point is that PERC never applies to a high-probability patient. Using PERC to dismiss a high-risk presentation is a classic wrong answer, and the two tools serve different steps in the workup.

How do you diagnose PE when a patient can't get contrast?

Use a ventilation-perfusion (V/Q) scan. It's the go-to alternative to CT pulmonary angiography when the patient has renal impairment, a contrast allergy, or a reason to minimize radiation exposure. A V/Q scan diagnoses PE by showing a mismatch: a perfusion defect in a lung segment that ventilates normally. It performs best when the baseline chest X-ray is clear and becomes hard to interpret in patients with significant underlying lung disease. In pregnancy, many protocols start with a lower-extremity compression ultrasound before deciding between CTA and V/Q.

When is a PE treated with thrombolytics instead of anticoagulation?

Thrombolytics (such as tPA) are reserved for massive PE, meaning sustained hypotension or shock caused by the embolism, in a patient without a contraindication to bleeding. A hemodynamically stable PE, even a large one on imaging, is treated with anticoagulation. The trap boards set is defining "massive" by clot size or a mildly elevated troponin rather than by blood pressure. If the patient is normotensive, the default is anticoagulation. Submassive PE (right ventricular strain without hypotension) is anticoagulated, with thrombolysis considered only in select cases.

Which anticoagulant is used for PE in pregnancy?

Low-molecular-weight heparin. Warfarin is teratogenic and is avoided in pregnancy, and direct oral anticoagulants (apixaban, rivaroxaban) are also avoided because of insufficient safety data and placental transfer concerns. LMWH does not cross the placenta and is the standard choice. This is a high-yield Step 2 CK and COMLEX Level 2-CE distractor, since the DOAC that would be first-line in a nonpregnant patient becomes the wrong answer the moment the stem mentions pregnancy.

Related guides

• High-yield abdominal imaging for COMLEX and USMLE
• How to review practice questions efficiently
• How to pick focused question blocks based on weak areas
• Doctor Lucas DO on YouTube: high-yield imaging and clinical comparison breakdowns